October 17, 2025 Release Highlights Copied
Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS) and Enhancing Oncology Model (EOM).
MIPS Quality Measures Dashboard
The MIPS Quality Measures Dashboard will be updated to reflect the following refinement(s):
| Measure | Update | Practice Impact |
| PIMSH 4: Patient-Reported Pain Improvement | Technical fix to ensure all subsequent visits with pain improvement documented have the appropriate numerator credit attributed where visits with 95-modifiers had previously been omitted.
Technical fix to ensure that a patient has multiple pain scores entered on the same date to attribute credit to the most recently entered pain encounter throughout the end of the episode window. |
Practices will notice a shift in Numerator and/or Denominator. |
| MIPS 143: Pain Intensity Quantified | Technical fix to ensure telehealth encounters for Radiation Therapy visits are included as denominator acceptable criteria.
Added in 95 telehealth modifier code for applicable telehealth visits per guidance from CMS. |
Practices will notice a shift in Numerator and/or Denominator. |
| MIPS 144: Pain Care Plan | Technical fix to ensure Radiation Therapy telehealth visits from MIPS 143 are removed from the denominator population of MIPS 144, per measure specifications. | Practices will not notice any impact to Numerator or Denominator. |
| MIPS 487: Screening for Social Drivers of Health | Technical fix to ensure the correct measure specific CPT codes are allowed where additional codes had previously been used. | Practices will notice a shift in Denominator and/or Numerator. |
| CQM/Registry & Custom measures Telehealth update | Technical fix to ensure the telehealth applicable measures have the appropriate telehealth codes in the denominator criteria.
Ensured the following CPT codes are accounted: 98000, 98001, 98002, 98003, 98004, 98005, 98006, 98007 Ensured the following modifiers are accounted: GQ, GT, POS 02, POS 10, 95 Ensured the following E/M codes are accounted: 99202, 99203, 99205, 99212, 99213, 99214, 99215 Note: eCQMs may have additional value sets that apply. |
Practices will notice a shift in Denominator and/or Numerator. |
The following measures are undergoing technical refinement and require additional work. A release date has not yet been determined:
- MIPS 134 Registry
- PIMSH 18
EOM Performance Measures Dashboard
The EOM Performance Measures Dashboard will be updated to reflect the following refinement(s):
| Measure | Update | Practice Impact |
| EOM measures Telehealth update | Technical fix to ensure the telehealth applicable measures have the appropriate telehealth codes in the denominator criteria.
Ensured the following CPT codes are accounted: 98000, 98001, 98002, 98003, 98004, 98005, 98006, 98007 Ensured the following modifiers are accounted: GQ, GT, POS 02, POS 10, 95 Ensured the following E/M codes are accounted: 99202, 99203, 99205, 99212, 99213, 99214, 99215 |
Practices will notice a shift in Denominator and/or Numerator. |
The EOM-5 measure is undergoing technical refinement and requires additional work. A release date has not yet been determined.
Status of Dashboard Updates for 2025
CMS releases updates to the quality measure specifications annually for the MIPS program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. Ontada will continue to notify practices once measures have been updated based on the current 2025 requirements.
| Measure Number | Description |
| MIPS Quality Measures Dashboard | |
| MIPS #001 | Diabetes Hemoglobin A1c (HbA1cc) Poor Control (>9%) (Inverse Measure) |
| MIPS #047 | Advance Care Plan |
| MIPS #130 | Current Medications Documentation |
| MIPS #134 eCQM | Preventive Care Screening: Screening for Depression and Follow Up Plan |
| MIPS #134 CQM/Registry | Preventive Care Screening: Screening for Depression and Follow Up Plan |
| MIPS #143 | Pain Intensity Quantified |
| MIPS #144 | Pain Care Plan |
| MIPS #226 | Tobacco Screening and Cessation |
| MIPS #236 | Controlling High Blood Pressure |
| MIPS #238 | Use of High-Risk Medications in Older Adults (Inverse Measure) |
| MIPS #374 | Closing the Referral Loop |
| MIPS #450 | Appropriate Treatment for Patients with Stage I (T1c) III Her2 Positive Breast Cancer |
| MIPS #451 | RAS (KRAS & NRAS) Testing Performed for Patients with Metastatic Colorectal Cancer who Receive Anti-EGFR Monoclonal Antibody Therapy |
| MIPS #453 | Proportion Receiving Chemotherapy in the Last 14 Days of Life (Inverse Measure) |
| MIPS #457 | Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days |
| MIPS #462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
| MIPS #487 | Screening for Social Drivers of Health |
| PIMSH #1 | Advance Care Planning in Metastatic Disease |
| PIMSH #4 | Patient-Reported Pain Improvement |
| PIMSH #9 | Supportive Care Drug Utilization in the Last 14 Days of Life (Inverse Measure) |
| PIMSH #10 | Hepatitis B Serology Testing and Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs |
| PIMSH #13 | Proportion of Stage IV nsNSCLC Patients Tested for Actionable Biomarkers and Received Mutation-Targeted Therapy |
| PIMSH #15 | Antiemetic Therapy for Low-and Minimal-Emetic-Risk Antineoplastic Agents in the Infusion Center-Avoidance of Overuse (Inverse Measure) |
| PIMSH #16 | Appropriate Antiemetic Therapy for High-and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center |
| PIMSH #17 | Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (Inverse Measure) |
| PIMSH #18 | Resolution or Improvement of a Health-Related Social Need |
| EOM Performance Measures Dashboard | |
| EOM-4A | Pain Intensity Quantified |
| EOM-4B | Pain Care Plan |
| EOM-5 | Preventive Care Screening: Screening for Depression and Follow Up Plan |